Serum Cytokine Levels Compared in Behçet's Disease
By LabMedica International staff writers Posted on 23 Aug 2015 |
Behçet's disease (BD) is a chronic systemic inflammatory disorder, stands out from other autoimmune and auto-inflammatory diseases due to its unique properties and is characterized by recurrent episodes of oral and genital ulcers, uveitis, and various systems involvement.
The onset of BD usually occurs in the third or fourth decade, and it is rare in children or patients over the age of 50, and the disease shows a male preponderance in Middle Eastern countries and the Mediterranean basin, conversely, women are more commonly affected in Japan and Korea.
Scientists at the Dicle University Faculty of Medicine (Diyarbakır, Turkey) investigated and compared the serum levels of various cytokines in patients with BD and healthy controls. In the study there were 10 patients with active BD, seven males and three females, and 25 patients with inactive BD, 11 males and 14 females. The mean ages of the groups were 31.90 ± 3.51 years, 33.80 ± 10.85 years, and 29.97 ± 12.43 years in active BD, inactive BD and controls, respectively.
The serum interleukin (IL)-2, IL-6, IL-8, IL-10, and interferon (IFN)-γ (Invitrogen; Carlsbad, CA, USA) and IL-17A (Biosource Europe S. A.; Nivelles, Belgium) levels were determined using the enzyme-linked immunosorbent assay method. Mean serum IL-8 levels of active BD patients was 2.04 ± 0.33 pg/mL which were higher compared to inactive BD patients of 1.81 ± 0.28 pg/mL and healthy controls whose mean level was 1.82 ± 0.20 pg/ml. IL-8 levels were correlated with the duration of symptoms and time passed since diagnosis. Serum levels of IL-2, 6, 10, 17A, and IFN- γ were similar in all study groups.
The authors concluded that Behçet's disease involves complex interactions of cells of the immune system, mainly T lymphocytes and neutrophils and various alterations in cytokine signaling seem to play a major role in its pathogenesis. The study was published in the July 2015 issue of the Journal of Clinical Laboratory Analysis.
Related Links:
Dicle University Faculty of Medicine
Invitrogen
Biosource Europe
The onset of BD usually occurs in the third or fourth decade, and it is rare in children or patients over the age of 50, and the disease shows a male preponderance in Middle Eastern countries and the Mediterranean basin, conversely, women are more commonly affected in Japan and Korea.
Scientists at the Dicle University Faculty of Medicine (Diyarbakır, Turkey) investigated and compared the serum levels of various cytokines in patients with BD and healthy controls. In the study there were 10 patients with active BD, seven males and three females, and 25 patients with inactive BD, 11 males and 14 females. The mean ages of the groups were 31.90 ± 3.51 years, 33.80 ± 10.85 years, and 29.97 ± 12.43 years in active BD, inactive BD and controls, respectively.
The serum interleukin (IL)-2, IL-6, IL-8, IL-10, and interferon (IFN)-γ (Invitrogen; Carlsbad, CA, USA) and IL-17A (Biosource Europe S. A.; Nivelles, Belgium) levels were determined using the enzyme-linked immunosorbent assay method. Mean serum IL-8 levels of active BD patients was 2.04 ± 0.33 pg/mL which were higher compared to inactive BD patients of 1.81 ± 0.28 pg/mL and healthy controls whose mean level was 1.82 ± 0.20 pg/ml. IL-8 levels were correlated with the duration of symptoms and time passed since diagnosis. Serum levels of IL-2, 6, 10, 17A, and IFN- γ were similar in all study groups.
The authors concluded that Behçet's disease involves complex interactions of cells of the immune system, mainly T lymphocytes and neutrophils and various alterations in cytokine signaling seem to play a major role in its pathogenesis. The study was published in the July 2015 issue of the Journal of Clinical Laboratory Analysis.
Related Links:
Dicle University Faculty of Medicine
Invitrogen
Biosource Europe
Read the full article by registering today, it's FREE!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Immunology News
- Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
- AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
- Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
- Testing Method Could Help More Patients Receive Right Cancer Treatment
- Groundbreaking Test Monitors Radiation Therapy Toxicity in Cancer Patients
- State-Of-The Art Techniques to Investigate Immune Response in Deadly Strep A Infections
- Novel Immunoassays Enable Early Diagnosis of Antiphospholipid Syndrome
- New Test Could Predict Immunotherapy Success for Broader Range Of Cancers
- Simple Blood Protein Tests Predict CAR T Outcomes for Lymphoma Patients
- Cell Sorter Chip Technology to Pave Way for Immune Profiling at POC
- Chip Monitors Cancer Cells in Blood Samples to Assess Treatment Effectiveness
- Automated Immunohematology Approaches Can Resolve Transplant Incompatibility
- AI Leverages Tumor Genetics to Predict Patient Response to Chemotherapy
- World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw
- Predictive T-Cell Test Detects Immune Response to Viruses Even Before Antibodies Form
- Single Blood Draw to Detect Immune Cells Present Months before Flu Infection Can Predict Symptoms